Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs

ACS Nano ◽  
2015 ◽  
Vol 9 (8) ◽  
pp. 8291-8302 ◽  
Author(s):  
Francisca Araújo ◽  
Neha Shrestha ◽  
Mohammad-Ali Shahbazi ◽  
Dongfei Liu ◽  
Bárbara Herranz-Blanco ◽  
...  
1992 ◽  
Vol 21 (1-3) ◽  
pp. 145-153 ◽  
Author(s):  
H. Yoshida ◽  
C.-M. Lehr ◽  
W. Kok ◽  
H.E. Junginger ◽  
J.C. Verhoef ◽  
...  
Keyword(s):  

2019 ◽  
Vol 137 ◽  
pp. 104978 ◽  
Author(s):  
Lakshmi Tunki ◽  
Hitesh Kulhari ◽  
Lakshma Nayak Vadithe ◽  
Madhusudana Kuncha ◽  
Suresh Bhargava ◽  
...  

2019 ◽  
Vol Volume 14 ◽  
pp. 7743-7758 ◽  
Author(s):  
Lingli Long ◽  
Minghua Lai ◽  
Xuhong Mao ◽  
Jiahao Luo ◽  
Xin Yuan ◽  
...  

2016 ◽  
Vol 60 (1) ◽  
pp. 524-525
Author(s):  
Jooho Park ◽  
Ok Cheol Jeon ◽  
Jisuk Yun ◽  
Hwajung Nam ◽  
Jinha Hwang ◽  
...  

2015 ◽  
Vol 12 (3) ◽  
pp. 966-973 ◽  
Author(s):  
Jie Wang ◽  
Vipul Yadav ◽  
Alice L. Smart ◽  
Shinichiro Tajiri ◽  
Abdul W. Basit
Keyword(s):  

BioDrugs ◽  
2005 ◽  
Vol 19 (3) ◽  
pp. 165-177 ◽  
Author(s):  
Josias H Hamman ◽  
Gill M Enslin ◽  
Awie F Kotz??
Keyword(s):  

2021 ◽  
Vol 75 (6) ◽  
pp. 514-517
Author(s):  
Xu-Dong Kong ◽  
Christian Heinis

Peptides have a number of attractive properties that make them an interesting modality for drug development, including their ability to bind challenging targets, their high target specificity, and their non-toxic metabolic products. However, a major limitation of peptides as drugs is their typically poor oral availability, hindering their convenient and flexible application as pills. Of the more than 60 approved peptide drugs, the large majority is not orally applicable. The oral delivery of peptides is hampered by their metabolic instability and/or limited intestinal uptake. In this article, we review the barriers peptides need to overcome after their oral administration to reach disease targets, we highlight two recent successes of pharma companies in developing orally applicable peptide drugs, and we discuss efforts of our laboratory towards the generation of bioavailable cyclic peptides.


Sign in / Sign up

Export Citation Format

Share Document